Abstract:Sarah-Eve Lemay 1 , Steeve Provencher 1,2 , Sébastien Bonnet 1,2 , François Potus 1,2 , Olivier Boucherat 1,2 1 Pulmonary Hypertension Research Group, Québec Heart and Lung Institute Research Centre, Québec City, QC, Canada; 2 Department of Medicine, Laval University, Québec City, QC, Canada Comment on: Tai YY, Yu Q, Tang Y, et al . Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension. Sci Transl Med 2024;16:eadd2029. Keywords: Pulmonary arterial hypertension (PAH); vascular remodeling; long non-coding RNA (lncRNA); hypoxia; pulmonary artery endothelial cells (PAECs) Submitted Mar 11, 2024. Accepted for publication Apr 28, 2024. Published online May 28, 2024. doi: 10.21037/atm-24-54 Pulmonary hypertension (PH) encompasses an heterogenous group of disorders, all hemodynamically defined by a mean pulmonary artery (PA) pressure >20 mmHg and characterized by endothelial injury and dysfunction, excessive vasoconstriction, and abnormal vascular remodeling of small PAs (1,2). These changes cause an increase in pulmonary vascular resistance, which ultimately results in right ventricular failure (2). Patients with PH are classified into five groups based upon etiology and mechanism. Although uncommon compared to other forms of PH, pulmonary arterial hypertension (PAH; group 1 PH) is the most severe and best studied subtype (3). Additionally, PH frequently complicates the clinical course of patients with lung diseases and/or hypoxemia, such as chronic obstructive pulmonary disease and interstitial lung disease (group 3 PH). This comorbidity exacerbates the already elevated morbidity and mortality rates associated with these conditions (4). Despite intense research endeavors and Food and Drug Administration (FDA)-approved drugs that mainly target pulmonary vasoconstriction (2,3,5), the prognosis of patients with group 1 and group 3 PH remains poor, emphasizing the urgent need for a better understanding of the molecular mechanisms leading to vascular remodeling. Activation of hypoxia-inducible factors (HIFs) is a hallmark of various subtypes of PH and a driving force in reprogramming the cellular metabolic and epigenetic landscape of PA resident cells (6,7). Among the different oxygen-sensitive alpha subunits, HIF-2α has emerged to play a predominant role in mediating PA endothelial cell (PAEC) proliferation contributing to the development of occlusive intimal/neointimal lesions. Notably, inactivation of HIF-2α targeted to the pulmonary endothelium has been shown to confer protection against chronic hypoxia-induced PH to a greater extent compared to mice with pulmonary endothelial deletion of HIF-1α (8,9). Additionally, pharmacological inhibition of HIF-2α was reported to improve pulmonary vascular remodeling and hemodynamics in several preclinical models of established PH (10). Although HIF-2α is a central protagonist of pulmonary vascular remodeling, the molecular mechanisms mediating its effects and accounting for its upregulation in PAECs remain poorly characterized. Similarly, although the implication of epigenetic changes, such as histone modifications and non-coding RNAs, is gaining increasing attention at the forefront of PH research field, they are still at the beginning. In their recent article published in Science Translational Medicine (11) (summarized in Figure 1 ), Pr. Chan and colleagues provide comprehensive and compelling insights into the intricate relationship between hypoxia and epigenetic events, and its critical impact on metabolic reprogramming that favors PAEC proliferation. As a starting point, the authors identified a long non-coding RNA (lncRNA) called E22 , which was upregulated in the lungs of mice in which PH was induced by the combined exposure to hypoxia and a VEGF receptor antagonist. Interest in this lncRNA was piqued by its conserved syntenic location, positioned head-to-head with the histone lysine N-methyltransferase 2E ( KMT2E ) gene and its partially conserved sequence with human KMT2E-AS1 . Subsequent experiments showed that the increase in E22 , KMT2E-AS1 , and KMT2E transcripts was mainly detected in PAEC of remodeled PAs from both group 1 and group 3 PH patients and PH animal models with preferential nuclear localization. Furthermore, using a bidirectional approach in cultured endothelial cells, HIF-2α was identified as a key regulator of the lncRNA-KMT2E pair. Indeed, depletion of HIF-2α was found to abolish the up-regulation of KMT2E-AS1 and KMT2E transcripts under hypoxia, whereas forced expression of a constitutively active form of HIF-2α in normoxic cells led to opposite effects. Since its nuclear-enriched localization implies a role in chromatin remodeling and trans -Abstract Truncated-

Lipocalin‐2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension

Lactate dehydrogenase A (LDHA)-mediated lactate generation promotes pulmonary vascular remodeling in pulmonary hypertension

Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension.

Abstract 14485: LDHA-Lactate Promotes Smooth Muscle Remodeling and Pulmonary Hypertension Through Lactylation of TOP1 and EMILIN1

Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension

Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension

ALDH2 (Aldehyde Dehydrogenase 2) Protects Against Hypoxia-Induced Pulmonary Hypertension

Long non-coding RNA CASC2 suppresses pulmonary artery smooth muscle cell proliferation and phenotypic switch in hypoxia-induced pulmonary hypertension

Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway

Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α

A HIF-2α-dependent KMT2E-AS1/KMT2E axis orchestrates endothelial epigenetic and metabolic dysfunction in pulmonary hypertension

Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine/LOX-1 signaling-impelled intercellular communication

Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension

LncRNA MYOSLID Contributes to PH Via Targeting BMPR2 Signaling in Pulmonary Artery Smooth Muscle Cell

PFKFB3-mediated Endothelial Glycolysis Promotes Pulmonary Hypertension.

Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension Due to Endothelial-to-mesenchymal Transition.

Increased Glycolysis Contributes to Pulmonary Vascular Remodeling via ERK-dependent Calpain Activation in Pulmonary Arterial Hypertension

HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension

PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis

Enhanced lung endothelial glycolysis is implicated in the development of severe pulmonary hypertension in type 2 diabetes

PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension